Clinical Trial Update: Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer

View source ↗

Summary

A clinical trial investigating the efficacy and safety of trastuzumab-rezetecan in HER2-expressing breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Low Breast Cancer

Drugs mentioned

• Trastuzumab Rezetecan

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Trastuzumab-rezetecan, HER2-low Breast Cancer | Status: RECRUITING